Rifamycin dibenzylamide
Rifamycin dibenzylamide is an orally active Antibiotic. Rifamycin dibenzylamide inhibits the growth of Gram-positive bacteria, Gram-negative bacteria, and Mycobacterium tuberculosis. Rifamycin dibenzylamide exhibits protective activity against experimental Staphylococcal infections in mice. It can be used in studies related to Staphylococcal infections and Mycobacterium tuberculosis infections.
For research use only. We do not sell to patients.
- CAS No.: 17607-39-5
- Formula: C53H62N2O13
- Molecular Weight:935.06
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Antibiotic Isoforms
More
Biological Activity
Description
In Vitro
Rifamycin dibenzylamide (Compound 20) (18 h) inhibits the growth of a variety of bacteria, including Micrococcus aureus ATCC 6538, Streptococcus faecalis ATCC 10541, and Streptococcus hemolyticus C 203[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Experimental Staphylococcal infection[1]
-
Dosage:Various dosages
-
Administration:p.o., s.c.
-
Result:Showed an ED50 of ~50 mg/kg when administered orally and ~20 mg/kg when administered subcutaneously.
Chemical Information
-
CAS No. 17607-39-5
-
Molecular Weight 935.06
-
Formula C53H62N2O13
-
SMILES
C[C@H]1/C=C/C=C(C)\C(NC2=CC(OCC(N(CC3=CC=CC=C3)CC4=CC=CC=C4)=O)=C5C(C(O)=C(C)C6=C5C([C@](O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@H]1O)(C)O6)=O)=C2O)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Rifamycin dibenzylamide
- 17607-39-5
- Antibiotic
- Bacterial
- subcutaneous routes
- gram-positive bacteria
- mycobacterium tuberculosis infection
- in vivo protective activity
- mice
- oral effectiveness
- gram-negative bacteria
- Mycobacterium tuberculosis
- bacterial growth inhibitor
- staphylococcal infection
- Inhibitor
- inhibitor
- inhibit